×
For best experience we recommend to activate Javascript in your browser.
BRCA2 antibody (AA 2913-3151)
This Rabbit Polyclonal antibody specifically detects BRCA2 in WB, IHC, IP and ICC. It exhibits reactivity toward Rat.
Quick Overview for BRCA2 antibody (AA 2913-3151) (ABIN7613023)
Target
See all BRCA2 Antibodies
BRCA2
(Breast Cancer 2, Early Onset (BRCA2))
Reactivity
All reactivities for BRCA2 antibodies
Rat
Host
All hosts for BRCA2 antibodies
Rabbit
Clonality
All clonalities for BRCA2 antibodies
Polyclonal
Conjugate
All conjugates for BRCA2 antibodies
This BRCA2 antibody is un-conjugated
Application
All applications for BRCA2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-BRCA2 Antibody
(hide)
Binding Specificity
All epitopes for BRCA2 antibodies
AA 2913-3151
Purpose
Breast Cancer Susceptibility Protein 2 (BRCA2) Polyclonal Antibody
Sequence
Ala2913~Pro3151
Characteristics
The Breast Cancer Susceptibility Protein 2 (BRCA2) Polyclonal Antibody (Species: Rat) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for BRCA2
(hide)
Target
BRCA2
(Breast Cancer 2, Early Onset (BRCA2))
Alternative Name
BRCA2
UniProt
O35923
Pathways
DNA Damage Repair , M Phase , Maintenance of Protein Location
Recently viewed
(hide)
Chat with us , powered by LiveChat